High Tide Inc: One of the Largest Cannabis Retail Networks in Canada
"High tide is a global vertically integrated cannabis company. We make industry leading cannabis lifestyle products that we also retail through Canna …
Industry Leading Cannabis Products
"High tide is a global vertically integrated cannabis company. We make industry leading cannabis lifestyle products that we also retail through Canna Cabana and Smoker's Corner locations.
We continue to develop one of the largest cannabis retail networks in Canada and eventually all legal markets worldwide." - Raj Grover, President & CEO of High Tide Inc.
High Tide is an Alberta-based, downstream cannabis corporation focused on the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products.
It is a vertically-integrated company in the Canadian cannabis market, with portfolio subsidiaries including:
- RGR Canada Inc.
- Famous Brandz Inc.
- Kush West Distribution Inc.
- Smoker’s Corner Ltd.
- Grasscity.com
- Canna Cabana Inc.
- Majority of KushBar Inc.
High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Key industry investors in High Tide include Aurora Cannabis Inc. and FSD Pharma Inc.
About High tide
We are a modern cannabis retailer, the largest counter-culture chain in the country, a global manufacturer of cutting-edge cannabis accessories.
A national distributor to retailers across the nation, and the most sophisticated, fully-integrated cannabis enterprise in the country.
For more information on High Tide Inc. (HITI:CSE, 2LY:Frankfurt) please fill out the form below.
Latest Articles
Hot Companies
You might also like
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
.jpg)
